Previous 10 | Next 10 |
Invitae Corporation (NVTA) Q1 2021 Earnings Conference Call May 4, 2021 04:30 pm ET Company Participants Laura D'Angelo - Head, Investor Relations Sean George - Chief Executive Officer and Co-Founder Shelly Guyer - Chief Financial Officer Conference Call Participants Tycho Peterson - JP Morga...
Invitae Corporation (NVTA) is trading lower despite better-than-expected Q1 2021 financials announced by the company today.Several metrics point to the continuing growth momentum. Quarterly revenue has risen ~61% YoY to reach $103.6M a ~3% improvement from the previous quarter.The b...
Invitae (NVTA): Q1 Non-GAAP EPS of -$0.63; GAAP EPS of -$0.56 beats by $0.04.Revenue of $103.62M (+61.3% Y/Y) beats by $2.16M.Reported billable volume of 259,000 in the quarter, a 72% increase compared to 151,000 in the same period in 2020Reported average cost per billable unit of $290 in the...
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021 -- Increased quarterly revenue by 61% and volume by 72% year-over-year -- -- Hosting conference call and webcast today at 4:30pm Eastern/1:30pm Pacific -- PR Newswire ...
Invitae (NYSE:NVTA) is scheduled to announce Q1 earnings results on Tuesday, May 4th, after market close.The consensus EPS Estimate is -$0.60 (+25.0% Y/Y) and the consensus Revenue Estimate is $101.46M (+57.9% Y/Y).Over the last 2 years, NVTA has beaten EPS estimates 13% of the time and has b...
Invitae’s supposed market leadership in genetic testing is not reflected in its declining revenue growth trend and gross margin. Invitae has incurred, and expected to incur significant operating losses moving forward, with a relatively small cash pile, potentially causing furth...
Invitae has the product offering and managerial efficiency to take over the largely unconquered genetic testing market. Institutional interest is growing, with popular firms SoftBank and ARK Investment announcing multibillion-dollar stakes in the past month. The long-term prospect...
Cathie Wood’s flagship Ark Innovation ETF (ARKK) has been experiencing a sharp pullback since March. The continuing tech sell-off and rising Treasury yields have sapped the momentum from some of her biggest bets. We think four companies held by ARKK, namely Twilio (TWLO), Teladoc Healt...
Invitae to Open New Facility in North Carolina to Support Continued Growth PR Newswire SAN FRANCISCO , April 20, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced its plans to open a new laboratory and ...
Invitae to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021 PR Newswire SAN FRANCISCO , April 20, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first qua...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...